How to Switch from Compounded Semaglutide to Foundayo
With the FDA cracking down on compounded GLP-1s, switching to FDA-approved Foundayo is the safest path forward. Here's how.
Why Switch from Compounded Semaglutide Now?
The compounded GLP-1 landscape is collapsing:
- FDA enforcement: The FDA has removed semaglutide from the shortage list, meaning compounding pharmacies can no longer legally produce it
- Quality concerns: Multiple FDA warnings about contaminated, sub-potent, or super-potent compounded products
- Supply unreliability: Your compounding pharmacy could stop selling semaglutide at any time
- No insurance coverage: Compounded medications are never covered by insurance
- Foundayo is affordable: At $149-349/month (dose-dependent) (or $25 with savings card), it's price-competitive with many compounded sources
Bottom line: Don't wait until your compounding pharmacy shuts down or your batch is contaminated. Switch to an FDA-approved option now.
The Dose Problem with Compounded Semaglutide
One of the biggest challenges in switching from compounded semaglutide is dose uncertainty. Compounding pharmacies may not provide the exact dose they claim:
- FDA testing has found compounded semaglutide ranging from 50% to 150% of labeled dose
- Your "5mg weekly" injection might actually be delivering anywhere from 2.5mg to 7.5mg
- This makes dose mapping to Foundayo less precise
Practical approach: Start Foundayo at 0.8mg regardless of your compounded dose. Your doctor will titrate based on your response, not a theoretical equivalence.
Transition Plan
The switch is straightforward:
- Take your last compounded semaglutide dose
- Start Foundayo 0.8mg daily the next day
- Follow standard titration schedule
Since compounded semaglutide is the same molecule as Ozempic/Wegovy, the transition pharmacology is the same. No washout needed.
Step-by-Step: How to Make the Switch
Cost Comparison
| Medication | Self-Pay/mo | With Savings Card |
|---|---|---|
| Compounded semaglutide | $200-500/mo | N/A |
| Foundayo | $149-349/mo | $25/mo |
Calculate Your Personalized Switch Plan
Enter your current medication and dose to get a detailed switching plan with dose mapping, timeline, and cost analysis.
Frequently Asked Questions
Sources & Citations
- FDA statement on semaglutide compounding and shortage resolution
- FDA warning letters to compounding pharmacies (2024-2025)
- Foundayo (orforglipron) FDA Prescribing Information
Stay Updated
Get notified when Foundayo pricing changes, new GLP-1 options become available, or new switching data is published.Plus personalized updates for your Compounded Semaglutide → Foundayo switch.
No spam. Unsubscribe anytime. We never share your email.
Ready to Make the Switch?
Talk to a doctor about switching to Foundayo. These telehealth providers offer online consultations and GLP-1 prescriptions.
MedSwitcher may earn a commission from some providers. This does not affect our recommendations. Our switch plans are based on clinical data, not partnerships.